Stock Taper
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
INKT
— MiNK Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 15, 2026
REVENUE
$0
EPS
-$0.57
-3.6%
FREE CASH FLOW
-$1.7M
+16.5%
No summary has been written for this call yet.
← NEWER CALL
CALL 2 OF 4
OLDER CALL →